Chugai’s Eldecalcitol Challenge Fails In Japan
Sawai And Nichi-Iko Had Been Targeted By Edirol Originator
Executive Summary
Chugai has seen its attack on Sawai and Nichi-Iko over their generic eldecalcitol rivals to the originator’s Edirol brand dismissed by a Tokyo district court.
You may also be interested in...
Sawai Focuses On New Products, Supply To 'Retain Trust' of Japan Generic Industry
Looking back at recent company decisions to shift product strategy, restructure its US Upsher-Smith business and acquire manufacturing sites from a former domestic competitor, Sawai's president shares the breadth of the Japanese firm’s vision.
Sawai Focuses On New Products, Supply To 'Retain Trust' of Japan Generic Industry
Looking back at recent company decisions to shift product strategy, restructure its US Upsher-Smith business and acquire manufacturing sites from a former domestic competitor, Sawai's president shares the breadth of the Japanese firm’s vision.
Japanese Firms Pursued Over Edirol Ingredient
Chugai is pursuing further Japanese litigation over generic rivals to its Edirol brand, this time concerning the eldecalcitol ingredient produced by Nissan Chemical.